• Nosiheptide packaged and labeled in glass vial.

click on thumbnail to zoom
SKU: N042

  Click 'Bulk Order' for 10 or more
Price: make selection(s)
Nosiheptide is a bicyclic thiopeptide antibiotic produced by several species of actinomycetes, notably Streptomyces, first reported by Japanese researchers in 1970. Unlike other bicyclic thiopeptides such as thiostrepton, the second macrocyclic ring is linked by relatively fragile lactone and thiolactone bridges to the core cyclic peptide. Nosiheptide has broad spectrum antibacterial activity, and has recently demonstrated a prolonged post-antibiotic effect in both nosocomial and community-acquired MRSA compared with vancomycin. Despite its long history in animal health, nosiheptide has not been extensively studied and is regarded as a "lost antibiotic" largely escaping intensive investigation for human application.

Nosiheptide is soluble in ethanol, methanol, DMF or DMSO. 

    CAS Number


    Molecular Formula


    Molecular Weight


    Storage Conditions




    Yellow solid



    A new antibiotic, multhiomycin. Tanaka T. et al. J. Antibiot. 1970, 23, 231.

    Identity of multhiomycin with nosiheptide. Endo T. and Yonehara H. J. Antibiot, 1978, 31, 623.

    Thiostrepton group of antibiotics. Pestka S. and Bodley J. Antibiotics. III. 1975, 551-573 ed. Corcoran J.W. & Harn F.E., Springer-Verlag, New York.

    Activity of the thiopeptide antibiotic, nosiheptide, against contemporary strains of methicillin-resistant Staphylococcus aureus. Haste N.M. et al. J. Antibiot. 2012, 65, 593.

Other Items In This Category